カテゴリー： QYResearch, 世界

世界の非チロシンキナーゼ阻害剤市場 2019年

【英語タイトル】Global Non-Tyrosine Kinase Inhibitors Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X12094）・商品コード：DATA909X12094
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：112
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、非チロシンキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、非チロシンキナーゼ阻害剤の世界市場を分析しました。


・エグゼクティブ・サマリー
・非チロシンキナーゼ阻害剤の世界市場概要
・非チロシンキナーゼ阻害剤の製造コスト構成分析
・非チロシンキナーゼ阻害剤の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・非チロシンキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・非チロシンキナーゼ阻害剤のセグメント分析（種類別）
（mTOR阻害剤、RAF / MEK阻害剤、CDK阻害剤）
・非チロシンキナーゼ阻害剤のセグメント分析（用途別）
（肝臓がん、呼吸器がん、脳がん、その他）
・非チロシンキナーゼ阻害剤の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Roche、Eli Lilly、Novartis、Array BioPharma、Nerviano Medical Sciences、Pfizer、Merck KGaA、Astex Pharmaceuticals、Cyclacel Pharmaceuticals、Daiichi Sankyo、Onconova Therapeutics、AstraZeneca、GlaxoSmithKline (GSK)、Carna Biosciences、Celgene Corporation、Eternity Bioscience、Jasco Pharmaceuticals、）
・非チロシンキナーゼ阻害剤の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Non-Tyrosine Kinase Inhibitors market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Non-Tyrosine Kinase Inhibitors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Tyrosine Kinase Inhibitors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Non-Tyrosine Kinase Inhibitors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Non-Tyrosine Kinase Inhibitors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Roche
Eli Lilly
Novartis
Array BioPharma
Nerviano Medical Sciences
Pfizer
Merck KGaA
Astex Pharmaceuticals
Cyclacel Pharmaceuticals
Daiichi Sankyo
Onconova Therapeutics
AstraZeneca
GlaxoSmithKline (GSK)
Carna Biosciences
Celgene Corporation
Eternity Bioscience
Jasco Pharmaceuticals

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
mTOR Inhibitors
RAF/MEK Inhibitors
CDK Inhibitors

Segment by Application
Liver Cancer
Respiratory Cancer
Brain Cancer
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Non-Tyrosine Kinase Inhibitors
1.1 Definition of Non-Tyrosine Kinase Inhibitors
1.2 Non-Tyrosine Kinase Inhibitors Segment by Type
1.2.1 Global Non-Tyrosine Kinase Inhibitors Production Growth Rate Comparison by Types (2014-2025)
1.2.2 mTOR Inhibitors
1.2.3 RAF/MEK Inhibitors
1.2.4 CDK Inhibitors
1.3 Non-Tyrosine Kinase Inhibitors Segment by Applications
1.3.1 Global Non-Tyrosine Kinase Inhibitors Consumption Comparison by Applications (2014-2025)
1.3.2 Liver Cancer
1.3.3 Respiratory Cancer
1.3.4 Brain Cancer
1.3.5 Others
1.4 Global Non-Tyrosine Kinase Inhibitors Overall Market
1.4.1 Global Non-Tyrosine Kinase Inhibitors Revenue (2014-2025)
1.4.2 Global Non-Tyrosine Kinase Inhibitors Production (2014-2025)
1.4.3 North America Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
1.4.4 Europe Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
1.4.5 China Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
1.4.6 Japan Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
1.4.7 Southeast Asia Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)
1.4.8 India Non-Tyrosine Kinase Inhibitors Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors
2.3 Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors
2.4 Industry Chain Structure of Non-Tyrosine Kinase Inhibitors

3 Development and Manufacturing Plants Analysis of Non-Tyrosine Kinase Inhibitors
3.1 Capacity and Commercial Production Date
3.2 Global Non-Tyrosine Kinase Inhibitors Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Non-Tyrosine Kinase Inhibitors
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Non-Tyrosine Kinase Inhibitors Production and Capacity Analysis
4.2 Non-Tyrosine Kinase Inhibitors Revenue Analysis
4.3 Non-Tyrosine Kinase Inhibitors Price Analysis
4.4 Market Concentration Degree

5 Non-Tyrosine Kinase Inhibitors Regional Market Analysis
5.1 Non-Tyrosine Kinase Inhibitors Production by Regions
5.1.1 Global Non-Tyrosine Kinase Inhibitors Production by Regions
5.1.2 Global Non-Tyrosine Kinase Inhibitors Revenue by Regions
5.2 Non-Tyrosine Kinase Inhibitors Consumption by Regions
5.3 North America Non-Tyrosine Kinase Inhibitors Market Analysis
5.3.1 North America Non-Tyrosine Kinase Inhibitors Production
5.3.2 North America Non-Tyrosine Kinase Inhibitors Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Non-Tyrosine Kinase Inhibitors Import and Export
5.4 Europe Non-Tyrosine Kinase Inhibitors Market Analysis
5.4.1 Europe Non-Tyrosine Kinase Inhibitors Production
5.4.2 Europe Non-Tyrosine Kinase Inhibitors Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Non-Tyrosine Kinase Inhibitors Import and Export
5.5 China Non-Tyrosine Kinase Inhibitors Market Analysis
5.5.1 China Non-Tyrosine Kinase Inhibitors Production
5.5.2 China Non-Tyrosine Kinase Inhibitors Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Non-Tyrosine Kinase Inhibitors Import and Export
5.6 Japan Non-Tyrosine Kinase Inhibitors Market Analysis
5.6.1 Japan Non-Tyrosine Kinase Inhibitors Production
5.6.2 Japan Non-Tyrosine Kinase Inhibitors Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Non-Tyrosine Kinase Inhibitors Import and Export
5.7 Southeast Asia Non-Tyrosine Kinase Inhibitors Market Analysis
5.7.1 Southeast Asia Non-Tyrosine Kinase Inhibitors Production
5.7.2 Southeast Asia Non-Tyrosine Kinase Inhibitors Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Non-Tyrosine Kinase Inhibitors Import and Export
5.8 India Non-Tyrosine Kinase Inhibitors Market Analysis
5.8.1 India Non-Tyrosine Kinase Inhibitors Production
5.8.2 India Non-Tyrosine Kinase Inhibitors Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Non-Tyrosine Kinase Inhibitors Import and Export

6 Non-Tyrosine Kinase Inhibitors Segment Market Analysis (by Type)
6.1 Global Non-Tyrosine Kinase Inhibitors Production by Type
6.2 Global Non-Tyrosine Kinase Inhibitors Revenue by Type
6.3 Non-Tyrosine Kinase Inhibitors Price by Type

7 Non-Tyrosine Kinase Inhibitors Segment Market Analysis (by Application)
7.1 Global Non-Tyrosine Kinase Inhibitors Consumption by Application
7.2 Global Non-Tyrosine Kinase Inhibitors Consumption Market Share by Application (2014-2019)

8 Non-Tyrosine Kinase Inhibitors Major Manufacturers Analysis
8.1 Roche
8.1.1 Roche Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.1.2 Roche Product Introduction, Application and Specification
8.1.3 Roche Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Eli Lilly
8.2.1 Eli Lilly Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.2.2 Eli Lilly Product Introduction, Application and Specification
8.2.3 Eli Lilly Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Novartis
8.3.1 Novartis Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.3.2 Novartis Product Introduction, Application and Specification
8.3.3 Novartis Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Array BioPharma
8.4.1 Array BioPharma Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.4.2 Array BioPharma Product Introduction, Application and Specification
8.4.3 Array BioPharma Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Nerviano Medical Sciences
8.5.1 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.5.2 Nerviano Medical Sciences Product Introduction, Application and Specification
8.5.3 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Pfizer
8.6.1 Pfizer Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.6.2 Pfizer Product Introduction, Application and Specification
8.6.3 Pfizer Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Merck KGaA
8.7.1 Merck KGaA Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.7.2 Merck KGaA Product Introduction, Application and Specification
8.7.3 Merck KGaA Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Astex Pharmaceuticals
8.8.1 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.8.2 Astex Pharmaceuticals Product Introduction, Application and Specification
8.8.3 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Cyclacel Pharmaceuticals
8.9.1 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.9.2 Cyclacel Pharmaceuticals Product Introduction, Application and Specification
8.9.3 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Daiichi Sankyo
8.10.1 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
8.10.2 Daiichi Sankyo Product Introduction, Application and Specification
8.10.3 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Onconova Therapeutics
8.12 AstraZeneca
8.13 GlaxoSmithKline (GSK)
8.14 Carna Biosciences
8.15 Celgene Corporation
8.16 Eternity Bioscience
8.17 Jasco Pharmaceuticals

9 Development Trend of Analysis of Non-Tyrosine Kinase Inhibitors Market
9.1 Global Non-Tyrosine Kinase Inhibitors Market Trend Analysis
9.1.1 Global Non-Tyrosine Kinase Inhibitors Market Size (Volume and Value) Forecast 2019-2025
9.2 Non-Tyrosine Kinase Inhibitors Regional Market Trend
9.2.1 North America Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.2.2 Europe Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.2.3 China Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.2.4 Japan Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.2.5 Southeast Asia Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.2.6 India Non-Tyrosine Kinase Inhibitors Forecast 2019-2025
9.3 Non-Tyrosine Kinase Inhibitors Market Trend (Product Type)
9.4 Non-Tyrosine Kinase Inhibitors Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Non-Tyrosine Kinase Inhibitors Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Non-Tyrosine Kinase Inhibitors
Table Global Non-Tyrosine Kinase Inhibitors Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Non-Tyrosine Kinase Inhibitors Production Market Share by Types in 2018
Figure mTOR Inhibitors Product Picture
Figure RAF/MEK Inhibitors Product Picture
Figure CDK Inhibitors Product Picture
Table Global Non-Tyrosine Kinase Inhibitors Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Non-Tyrosine Kinase Inhibitors Consumption Market Share by Applications in 2018
Figure Liver Cancer
Figure Respiratory Cancer
Figure Brain Cancer
Figure Others
Figure Global Non-Tyrosine Kinase Inhibitors Revenue (Million USD) (2014-2025)
Figure Global Non-Tyrosine Kinase Inhibitors Production (K Pcs) (2014-2025)
Figure North America Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Figure Europe Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Figure China Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Figure Japan Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Figure Southeast Asia Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Figure India Non-Tyrosine Kinase Inhibitors Market Size (Million USD) (2014-2025)
Table Non-Tyrosine Kinase Inhibitors Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Non-Tyrosine Kinase Inhibitors in 2018
Figure Manufacturing Process Analysis of Non-Tyrosine Kinase Inhibitors
Figure Industry Chain Structure of Non-Tyrosine Kinase Inhibitors
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Non-Tyrosine Kinase Inhibitors Manufacturing Plants Distribution
Table Non-Tyrosine Kinase Inhibitors Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Non-Tyrosine Kinase Inhibitors Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Non-Tyrosine Kinase Inhibitors Production (K Pcs) of Major Manufacturers (2014-2019)
Table Non-Tyrosine Kinase Inhibitors Production Market Share of Major Manufacturers (2014-2019)
Figure Non-Tyrosine Kinase Inhibitors Production Share by Manufacturers in 2018
Table Non-Tyrosine Kinase Inhibitors Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Non-Tyrosine Kinase Inhibitors Revenue Market Share of Major Manufacturers (2014-2019)
Figure Non-Tyrosine Kinase Inhibitors Revenue Share by Manufacturers in 2018
Table Non-Tyrosine Kinase Inhibitors Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Non-Tyrosine Kinase Inhibitors Production by Regions 2014-2019 (K Pcs)
Table Global Non-Tyrosine Kinase Inhibitors Production Market Share by Regions 2014-2019
Figure Global Non-Tyrosine Kinase Inhibitors Production Market Share by Regions in 2018
Table Global Non-Tyrosine Kinase Inhibitors Revenue by Regions 2014-2019 (Million USD)
Table Global Non-Tyrosine Kinase Inhibitors Revenue Market Share by Regions 2014-2019
Figure Global Non-Tyrosine Kinase Inhibitors Revenue Market Share by Regions in 2018
Table Global Non-Tyrosine Kinase Inhibitors Consumption by Regions 2014-2019 (K Pcs)
Table Global Non-Tyrosine Kinase Inhibitors Consumption Market Share by Regions 2014-2019
Figure North America Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure North America Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table North America Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Europe Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure China Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure China Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table China Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Japan Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure India Non-Tyrosine Kinase Inhibitors Production Growth Rate 2014-2019 (K Pcs)
Figure India Non-Tyrosine Kinase Inhibitors Revenue Growth Rate 2014-2019 (Million USD)
Table India Non-Tyrosine Kinase Inhibitors Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Non-Tyrosine Kinase Inhibitors Market Share by Application (2014-2019)
Figure Global Value (Consumption) Non-Tyrosine Kinase Inhibitors Market Share by Application (2014-2019)
Table Roche Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Roche Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Roche Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Roche Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Roche Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Roche Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Roche Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Eli Lilly Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Eli Lilly Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Novartis Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Novartis Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Novartis Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Novartis Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Novartis Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Novartis Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Array BioPharma Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Array BioPharma Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Pfizer Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Pfizer Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Pfizer Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Pfizer Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Pfizer Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Pfizer Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Merck KGaA Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Merck KGaA Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Product Introduction, Application and Specification
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production Growth Rate (2014-2019)
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Production Market Share (2014-2019)
Figure Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Revenue Market Share (2014-2019)
Table Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Main Business and Markets Served
Table Onconova Therapeutics Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table AstraZeneca Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Carna Biosciences Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Celgene Corporation Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Eternity Bioscience Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Table Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors Production Sites and Area Served
Figure Global Non-Tyrosine Kinase Inhibitors Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Non-Tyrosine Kinase Inhibitors Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Non-Tyrosine Kinase Inhibitors Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Non-Tyrosine Kinase Inhibitors Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Non-Tyrosine Kinase Inhibitors Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Non-Tyrosine Kinase Inhibitors by Type (2019-2025)
Table Global Consumption (K Pcs) of Non-Tyrosine Kinase Inhibitors by Application (2019-2025)
Table Non-Tyrosine Kinase Inhibitors Distributors List
Table Non-Tyrosine Kinase Inhibitors Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Roche、Eli Lilly、Novartis、Array BioPharma、Nerviano Medical Sciences、Pfizer、Merck KGaA、Astex Pharmaceuticals、Cyclacel Pharmaceuticals、Daiichi Sankyo、Onconova Therapeutics、AstraZeneca、GlaxoSmithKline (GSK)、Carna Biosciences、Celgene Corporation、Eternity Bioscience、Jasco Pharmaceuticals、

★調査レポート[世界の非チロシンキナーゼ阻害剤市場 2019年] (コード：DATA909X12094)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の非チロシンキナーゼ阻害剤市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のチロシンプロテインキナーゼCSK市場 2019年
    DATA909X16990 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼCSKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アパチニブ、ボスチニブ、CCT-196969、CCT-241161、その他に、用途別には、結腸がん、卵管がん、転移性乳がん、その他にセグメント区分し、チロシンプロテインキナーゼCSKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼCSKの世界市場概要 ・チロシンプロテインキナーゼCSKの製造コスト構成分析 ・チロシンプロテインキナーゼCSKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼCSKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼCSKのセグメント分析（種類別） （アパチニブ、ボスチニブ、CCT-196969、CCT-241161、その他）...The global Tyrosine Protein Kinase CSK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase CSK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase CSK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase CSK in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のチロシンプロテインキナーゼFyn市場 2019年
    DATA909X16991 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼFynの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ダサチニブ、マシチニブ、VAL-201、その他に、用途別には、アルツハイマー病、アルコール依存症、乳がん、がん性疼痛、その他にセグメント区分し、チロシンプロテインキナーゼFynの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼFynの世界市場概要 ・チロシンプロテインキナーゼFynの製造コスト構成分析 ・チロシンプロテインキナーゼFynの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼFynの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼFynのセグメント分析（種類別） （ダサチニブ、マシチニブ、VAL-201、その他）...The global Tyrosine Protein Kinase Fyn market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase Fyn volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase Fyn market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase Fyn in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のチロシンプロテインキナーゼITK市場 2019年
    DATA909X16992 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼITKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARN-4079、GNE-4997、JTE-051、塩酸パゾパニブ、その他に、用途別には、喘息、軟骨肉腫、膠芽腫、転移性腎細胞癌、その他にセグメント区分し、チロシンプロテインキナーゼITKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼITKの世界市場概要 ・チロシンプロテインキナーゼITKの製造コスト構成分析 ・チロシンプロテインキナーゼITKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼITKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼITKのセグメント分析（種類別） （ARN-4079、GNE-4997、JTE-051、塩酸パゾパニブ、その他）...The global Tyrosine Protein Kinase ITK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase ITK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase ITK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase ITK in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のチロシンプロテインキナーゼSYK市場 2019年
    DATA909X16993 / QYResearch / 2019年11月22日 / ※本調査レポートは、チロシンプロテインキナーゼSYKの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、HMPL-523、C-13、CVXL-0074、ASN-002、FF-10102、その他に、用途別には、アナフィラキシーショック、関節炎、卵管がん、ループス腎炎、その他にセグメント区分し、チロシンプロテインキナーゼSYKの世界市場を分析しました。 ・エグゼクティブ・サマリー ・チロシンプロテインキナーゼSYKの世界市場概要 ・チロシンプロテインキナーゼSYKの製造コスト構成分析 ・チロシンプロテインキナーゼSYKの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・チロシンプロテインキナーゼSYKの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・チロシンプロテインキナーゼSYKのセグメント分析（種類別） （HMPL-523、C-13、CVXL-0074、ASN-002、FF-10102、その他）...The global Tyrosine Protein Kinase SYK market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tyrosine Protein Kinase SYK volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tyrosine Protein Kinase SYK market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tyrosine Protein Kinase SYK in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の非受容体チロシンプロテインキナーゼTYK2市場 2019年
    DATA909X12041 / QYResearch / 2019年11月20日 / ※本調査レポートは、非受容体チロシンプロテインキナーゼTYK2の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ARRY-624、BMS-986165、セルデュラチニブ、NDI-031232、その他に、用途別には、濾胞性リンパ腫、過敏症、ループス腎炎、辺縁帯B細胞リンパ腫、その他にセグメント区分し、非受容体チロシンプロテインキナーゼTYK2の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非受容体チロシンプロテインキナーゼTYK2の世界市場概要 ・非受容体チロシンプロテインキナーゼTYK2の製造コスト構成分析 ・非受容体チロシンプロテインキナーゼTYK2の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非受容体チロシンプロテインキナーゼTYK2の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・非受容体チロシンプロテインキナーゼTYK2のセグメント分析（種類別） （ARRY-624、BMS-986165、セルデュラチニブ、NDI-031232、その他）...The global Non Receptor Tyrosine Protein Kinase TYK2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Non Receptor Tyrosine Protein Kinase TYK2 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non Receptor Tyrosine Protein Kinase TYK2 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Non Receptor Tyrosine Protein Kinase TYK2 in North America, Europe, China,...
  • 世界の受容体型チロシンプロテインキナーゼ市場 2019年
    DATA909X14155 / QYResearch / 2019年11月20日 / ※本調査レポートは、受容体型チロシンプロテインキナーゼの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、PB-357、NT-113、NRG-4、MIN-301、その他に、用途別には、皮膚がん、収縮期心不全、神経芽細胞腫、乏突起膠腫、その他にセグメント区分し、受容体型チロシンプロテインキナーゼの世界市場を分析しました。 ・エグゼクティブ・サマリー ・受容体型チロシンプロテインキナーゼの世界市場概要 ・受容体型チロシンプロテインキナーゼの製造コスト構成分析 ・受容体型チロシンプロテインキナーゼの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・受容体型チロシンプロテインキナーゼの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・受容体型チロシンプロテインキナーゼのセグメント分析（種類別） （PB-357、NT-113、NRG-4、MIN-301、その他）...The global Receptor Tyrosine Protein Kinase ERBB 4 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Receptor Tyrosine Protein Kinase ERBB 4 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Receptor Tyrosine Protein Kinase ERBB 4 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Receptor Tyrosine Protein Kinase ERBB 4 in North America, Europe, China,...
  • 世界のヤヌスキナーゼ（JAK）阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X01275 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のヤヌスキナーゼ（JAK）阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。ヤヌスキナーゼ（JAK）阻害剤の種類別には、自己免疫疾患、腫瘍学に、用途別には、クリニック、病院に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・ヤヌスキナーゼ（JAK）阻害剤の種類別市場規模：自己免疫疾患、腫瘍学 ・ヤヌスキナーゼ（JAK）阻害剤の用途別市場規模：クリニック、病院 ・ヤヌスキナーゼ（JAK）阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Astellas Pharma, Inc.、Eli...Janus kinase inhibitors are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway.In 2018, the global Janus Kinase (JAK) Inhibitors market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Janus Kinase (JAK) Inhibitors. This study researches the market...
  • 世界のBRAFキナーゼ阻害剤産業：成長傾向・競合分析2019-2025
    DATA909X00353 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界のBRAFキナーゼ阻害剤市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。BRAFキナーゼ阻害剤の種類別には、ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブに、用途別には、病院、医学研究所、クリニック、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・BRAFキナーゼ阻害剤の種類別市場規模：ダブラフェニブ、ソラフェニブ、ベムラフェニブ、エンコラフェニブ ・BRAFキナーゼ阻害剤の用途別市場規模：病院、医学研究所、クリニック、その他 ・BRAFキナーゼ阻害剤の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Array BioPharma Inc.、Bayer...BRAF kinase inhibitors are generally used as targeted therapy drugs for the treatment of carcinomas such as RCC, NSCLC, and melanomas caused by mutations of the BRAF gene.These drugs directly target BRAF protein and inhibit the growth of tumors in patients with metastatic melanoma. Such results delivered by the BRAF kinase inhibitors has encouraged several R&D teams to extend research on other applications. Moreover, many BRAF kinase inhibitor drugs are in the final stages of development and are expected to be launched during the forecast period. In 2018, the global BRAF Kinase Inhibitors market size was xx million US$ and...
  • 世界のプロテインキナーゼ阻害剤市場 2019年
    DATA909X13844 / QYResearch / 2019年11月20日 / ※本調査レポートは、プロテインキナーゼ阻害剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、セリン/スレオニンプロテインキナーゼ阻害剤、チロシンプロテインキナーゼ阻害剤に、用途別には、治療、診断、研究にセグメント区分し、プロテインキナーゼ阻害剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・プロテインキナーゼ阻害剤の世界市場概要 ・プロテインキナーゼ阻害剤の製造コスト構成分析 ・プロテインキナーゼ阻害剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・プロテインキナーゼ阻害剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・プロテインキナーゼ阻害剤のセグメント分析（種類別） （セリン/スレオニンプロテインキナーゼ阻害剤、チロシンプロテインキナーゼ阻害剤）...The global Protein Kinase Inhibitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Protein Kinase Inhibitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Protein Kinase Inhibitor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Protein Kinase Inhibitor in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆